Clinical Trial Update: Bi-weekly Cetuximab Combined With 5-fluorouracil/Leucovorin/Oxaliplatin (FOLFOX-6) in Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating bi-weekly cetuximab with FOLFOX-6 (5-fluorouracil, leucovorin, oxaliplatin) in metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Cetuximab (cetuximab)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Martin Schuler, Prof. Dr. med. | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED